In Ang II-induced cardiac hypertrophy mouse model, MD2 deficiency was found to reduce cardiac inflammation as well as subsequent fibrosis, hypertrophy, and dysfunction by disrupting the combination of MD2 and TLR4 (31), supporting a mechanism by which Ang II activates TLR4 in an MD2-dependent manner. The gene discussed is LY96; the disease is cardiac hypertrophy.